Interleukin-13 Increases Podocyte Apoptosis in Cultured Human Podocytes

키워드

참고문헌 (31)

1. Churg J, "Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children", Lancet, 760, pp.1299~1230 (1970)
2. Haas M, "Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997", Am J Kidney Dis, 30, pp.621~ (1997)[DOI]
3. Trompeter RS, "Longterm outcome for children with minimal-change nephrotic syndrome", Lancet, 1, pp.368~370 (1985)
4. "A report of the International Study of Kidney Disease in Children. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone", J Pediatr, 98, pp.561~564 (1981)[DOI]
5. Teeninga N, "Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome", J Am Soc Nephrol, 24, pp.149~159 (2013)[DOI]
6. Tarshish P, "Prognostic significance of the early course of minimal change nephrotic syndrome: Report of the International Study of Kidney Disease in Children", J Am Soc Nephrol, 8, pp.769~776 (1997)
7. Gipson DS, "Differential risk of remission and ESRD in childhood FSGS", Pediatr Nephrol, 21, pp.344~349 (2006)[DOI]
8. D'Agati VD, "Pathologic classification of focal segmental glomerulosclerosis", Semin Nephrol, 23, pp.117~134 (2003)[DOI]
9. Schnaper HW, "Idiopathic focal segmental glomerulosclerosis", Semin Nephrol, 23, pp.183~193 (2003)[DOI]
10. Pavenstadt H, "Cell biology of the glomerular podocyte", Physiol Rev, 83, pp.253~307 (2002)
11. Asanuma K, "The role of podocytes in glomerular pathobiology", Clin Exp Nephrol, 7, pp.255~259 (2003)[DOI]
12. McKenzie AN, "Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function", Proc Natl Acad Sci USA, 90, pp.3735~3740 (1993)[DOI]
13. Cheung W, "Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndrome", Pediatr Nephrol, 19, pp.627~632 (2004)[DOI]
14. 박세진, "Effects of Interleukin-13 and Montelukast on the Expression of Zonula Occludens-1 in Human Podocytes", Yonsei Medical Journal, 56(2), pp.426~432 (2015), 연세대학교의과대학[DOI]
15. Majno G, "Apoptosis, oncosis, and necrosis. An overview of cell death", Am J Pathol, 146, pp.3~15 (1995)
16. Gavrieli Y, "Identification of pro-grammed cell death in situ via specific labeling of nuclear DNA fragmentation", J Cell Biol, 119, pp.493~501 (1992)[DOI]
17. Lai KW, "Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats", J Am Soc Nephrol, 18, pp.1476~1485 (2007)[DOI]
18. Ha TS, "Montelukast improves the changes of cytoskeletal and adaptor proteins of human podocytes by interleukin-13", Inflamm Res, 66, pp.793~802 (2017)[DOI]
19. Yap HK, "Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse", J Am Soc Nephrol, 10, pp.529~537 (1999)
20. Kroemer G, "Mitochondrial membrane permeabilization in cell death", Physiol Rev, 87, pp.99~163 (2007)[DOI]
21. Ryu M, "Tumour necrosis factor-alpha drives Alport glomerulosclerosis in mice by promoting podocyte apoptosis", J Pathol, 226, pp.120~131 (2011)
22. Galluzzi L, "Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012", Cell Death Differ, 19, pp.107~120 (2012)[DOI]
23. Faleiro L, "Multiple species of CPP32 and Mch2 are the major active caspases present inapoptotic cells", EMBO J, 16, pp.2271~2281 (1997)[DOI]
24. Polverino AJ, "Selective activation of caspases during apoptotic induction in HL-60 cells", J Biol Chem, 272, pp.7013~7021 (1997)[DOI]
25. Zou H, "Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3", Cell, 90, pp.405~413 (1997)[DOI]
26. Manna SK, "IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis", J Immunol, 161, pp.2863~2872 (1998)
27. Kawakami M, "Apoptotic pathways of cell death induced by an interleukin-13 receptor-targeted recombinant cytotoxin in head and neck cancer cells", Cancer Immunol Immunother, 50, pp.691~700 (2002)[DOI]
28. Kawakami M, "Tumor regression mechanisms by IL-13 receptor-targeted cancer therapy involve apoptotic pathways", Int J Cancer, 103, pp.45~52 (2003)[DOI]
29. Borowski A, "Interleukin-13 acts as an apoptotic effector on lung epithelial cells and induces pro-fibrotic gene expression in lung fibroblasts", Clin Exp Allergy, 38, pp.619~628 (2008)[DOI]
30. Heller F, "Epithelial apoptosis is a prominent feature of the epithelial barrier disturbance in intestinal inflammation: effect of pro-inflammatory interleukin-13 on epithelial cell function", Mucosal Immunol, (1 Suppl 1), pp.58~61 (2008)
31. Friedrich K, "Interleukin- 4 and Interleukin-13 receptors trigger distinct JAK", STAT activation patterns in mouse lymphocytes, 2003, pp.3, 26~32

관련 논문AI추천